Landscapes / Companies
Mannkind Corporation not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 5 in all
Trials
2 active
10 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Mar 2027Phase 2 trial completes | |||
| Next date | Mar 2027 · Phase 2 trial completes | ||||
| Also tested for | Type 1 Diabetes Mellitus | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Dec 2027Phase 2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Open drug page | |||||
About
- No active trial
- Afrezza Inhalation Powder, Clofazimine Inhalation Suspension, MKND-201
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021